Open access
Jul 2026
Integrative Bioinformatics and Experimental Validation Reveal that METTL9 Drives Lung Adenocarcinoma Progression via TGF-β/Smad-Mediated EMT Activation.
The results indicate that METTL9 may contribute to LUAD progression and EMT, potentially in relation to the TGF-β/Smad signaling pathway, potentially in relation to the TGF-β/Smad signaling pathway.
Chen Gong, Yu-Yan Chen, Yuchen Xie et al.
· Frontiers in Bioscience · 0 citations